Table 3. Haplotype association with chronicity and clearance of HBV infection, with the most common haplotype, CGG, as the reference.

Haplotype	HBV carriers (%)	Non-HBV infected subjects (%)	HBV Clearance subjects (%)	OR (95% CI)*	p*	OR (95% CI)†	p†
CGG	597 (59.7%)	256 (52.2%)	256 (49.6%)	1	–	1	–
TAT	147 (14.7%)	106 (21.6%)	108 (20.9%)	0.62 (0.45–0.86)	0.0044	1.64 (1.21–2.24)	0.0013
CAT	80 (8%)	49 (10%)	66 (12.8%)	0.70 (0.45–1.09)	0.116	1.98 (1.35–2.90)	0.00041
CGT	102 (10.2%)	41 (8.4%)	50 (9.7%)	1.15 (0.76–1.74)	0.495	1.07 (0.74–1.56)	0.458
TGG	53 (5.3%)	28 (5.7%)	30 (5.8%)	0.70 (0.42–1.17)	0.177	1.31 (0.80–2.13)	0.213

All logistic regression analyses were adjusted for age and sex.

SNP order of haplotype: rs3077, rs9277378, rs3128917.

^*HBV carriers vs. non-HBV infected subjects.

^†Clearance subjects vs. HBV carriers.